Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Synthekine
Podcast
Where are they now? Catching up with past Fierce 15 honorees
This week on “The Top Line,” we catch up with past Fierce 15 honorees to gain their insights, experiences and visions for the biotech landscape.
Ayla Ellison
,
Gabrielle Masson
Oct 18, 2024 9:39am
Synthekine hopes new IL-2 will be the high-alpha in a beta class
Apr 10, 2024 9:50am
AbbVie names CEO successor—Chutes & Ladders
Feb 23, 2024 9:30am
Sanofi pays $40M to join preclinical push against vexing target
Jan 29, 2024 8:00am
Fierce Biotech's 2022 Fierce 15
Sep 12, 2022 3:00am
Merck inks $525M biobucks pact for Synthekine's cytokine target
Nov 1, 2021 8:00am
